
Novel highly мощный and orally active ABCB1 modulator capable of overcoming MDR, stabilizing ABCB1 by directly связывание to ABCB1, stimulating the activity of ABCB1 ATPase without inhibitory activity against CYP3A4, increasing the sensitivity of SW620/Ad300
Novel highly potent and orally active ABCB1 modulator capable of overcoming MDR, stabilizing ABCB1 by directly binding to ABCB1, stimulating the activity of ABCB1 ATPase without inhibitory activity against CYP3A4, increasing the sensitivity of SW620/Ad300
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.